非血病性:一种罕见的和意想不到的诊断死的
Beth B Richardson1, Marc A Stees2, Brandon R Gumbiner3
1*UW Health, Rockford, IL.
Journal of the American Podiatric Medical Association
|March 6, 2024
概括
非尿血性石灰症 (nonuremic calciphylaxis) 是患有正常功能患者的罕见病症,可能会出现疼痛的皮肤. 这一案例凸显了在差异诊断中考虑石灰的重要性,即使最初的测试结果是负面的.
科学领域:
- 皮肤病学 皮肤病学
- 腎臟病學 (nephrology) 是一種醫學.
- 病理学 病理学 病理学
背景情况:
- 卡尔西菲拉克西是一种罕见的,严重的疾病,通常在末期病患者中见到.
- 发生在具有功能保存的个体中,非性性非常罕见.
- 慢性死角性皮肤的诊断可能具有挑战性,特别是在非血性患者中.
研究的目的:
- 报告一个致命的非尿血性石灰症病例,诊断方面存在挑战.
- 强调化作为慢性死性皮肤的关键差异诊断.
- 提高临床医生对非尿血性石灰的认识,特别是在接受华法林治疗的患者中.
主要方法:
- 一位患有非尿血性石灰症的患者的病例报告.
- 对临床表现,实验室测试和活检结果的审查.
- 分析诊断延迟和导致因素.
主要成果:
- 患者出现了疼痛的腿部,并且最初的活检结果对化反应是负面的.
- 在课程期间,观察到甲状腺上腺激素升高和巴胺缺乏.
- 第二次活检证实了calciphylaxis,在显著的延迟后进行了诊断.
- 病人最终屈服于这种情况.
结论:
- 在无法解释的性皮肤的差异诊断中,应考虑非血性性.
- 尽管进行了早期调查,但诊断延迟可能会发生,需要重复评估.
- 华法林治疗和潜在的代谢障碍可能是相关因素.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
117
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
117
Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
Peptic Ulcer Disease II: Pathophysiology
424
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
424
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
485
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
485
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K


